Sangamo Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sangamo Therapeutics Stock Summary

Sangamo Therapeutics competes with Editas Medicine, Intellia Therapeutics, Bluebird Bio, and Alnylam Pharmaceuticals. Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California. Sangamo Therapeutics is traded on NASDAQ Exchange in the United States.

Sangamo Therapeutics Key Financial Ratios

Sangamo Therapeutics Key Balance Sheet Accounts

Sangamo Therapeutics Key Income Statement Accounts

Sangamo Therapeutics Key Cash Accounts

Sangamo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sangamo Therapeutics's current stock value. Our valuation model uses many indicators to compare Sangamo Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sangamo Therapeutics competition to find correlations between indicators driving Sangamo Therapeutics's intrinsic value. More Info.Sangamo Therapeutics is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Sangamo Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sangamo Therapeutics' earnings, one of the primary drivers of an investment's value.

Sangamo Therapeutics Systematic Risk

Today, most investors in Sangamo Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sangamo Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sangamo Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sangamo Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sangamo Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sangamo Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Sangamo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sangamo Therapeutics's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.